Subcutaneous Opdivo confirmed comparable efficacy and security to IV Opdivo in beforehand handled superior or metastatic clear cell renal cell carcinoma.Amongst sufferers with...
The First sufferers has been dosed in a part 1 trial of PHST001, a novel macrophage checkpoint inhibitor for superior strong tumors.Pheast Therapeutics...